TherapeuticsMD Inc Surprises Wall Street With Solid Q2 Results
TherapeuticsMD Inc (NASDAQ:TXMD) had been trending steadily lower since reporting less-than-enthralling first-quarter financial results in May.
But patient investors were rewarded in August when the company surprised Wall Street by reporting strong second-quarter results and raising its full-year guidance. Since then, the company's share price has doubled.
Trading at $3.74 at the time of this writing, TXMD stock remains bullish and continues to build on earlier gains. Analysts have changed their tune on TherapeuticsMD stock, with a 12-month price forecast of $20.00 per share. This represents.
Den vollständigen Artikel lesen ...
TherapeuticsMD Inc (NASDAQ:TXMD) had been trending steadily lower since reporting less-than-enthralling first-quarter financial results in May.
But patient investors were rewarded in August when the company surprised Wall Street by reporting strong second-quarter results and raising its full-year guidance. Since then, the company's share price has doubled.
Trading at $3.74 at the time of this writing, TXMD stock remains bullish and continues to build on earlier gains. Analysts have changed their tune on TherapeuticsMD stock, with a 12-month price forecast of $20.00 per share. This represents.
Den vollständigen Artikel lesen ...